Literature DB >> 26843672

Evaluation Framework for HIV Prevention and Care Activities in the Enhanced Comprehensive HIV Prevention Planning Project, 2010-2013.

Holly H Fisher1, Tamika Hoyte1, Stephen A Flores1, David W Purcell1, Erica Dunbar1, Dale Stratford1.   

Abstract

OBJECTIVE: The Enhanced Comprehensive HIV Prevention Planning (ECHPP) project was a demonstration project implemented by 12 U.S. health departments (2010-2013) to enhance HIV program planning in cities with high AIDS prevalence, in support of National HIV/AIDS Strategy goals. Grantees were required to improve their planning and implementation of HIV prevention and care programs to increase their impact on local HIV epidemics. A multilevel evaluation using multiple data sources, spanning multiple years (2008-2015), will be conducted to assess the effect of ECHPP on client outcomes (e.g., HIV risk behaviors) and impact indicators (e.g., new HIV diagnoses).
METHODS: We designed an evaluation approach that includes a broad assessment of program planning and implementation, a detailed examination of HIV prevention and care activities across funding sources, and an analysis of environmental and contextual factors that may affect services. A data triangulation approach was incorporated to integrate findings across all indicators and data sources to determine the extent to which ECHPP contributed to trends in indicators.
RESULTS: To date, data have been collected for 2008-2009 (pre-ECHPP implementation) and 2010-2013 (ECHPP period). Initial analysis of process data indicate the ECHPP grantees increased their provision of HIV testing, condom distribution, and partner services programs and expanded their delivery of prevention programs for people diagnosed with HIV.
CONCLUSION: The ECHPP evaluation (2008-2015) will assess whether ECHPP programmatic activities in 12 areas with high AIDS prevalence contributed to changes in client outcomes, and whether these changes were associated with changes in longer-term, community-level impact.

Entities:  

Mesh:

Year:  2016        PMID: 26843672      PMCID: PMC4716474          DOI: 10.1177/003335491613100113

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  4 in total

1.  Content analysis: method, applications, and issues.

Authors:  B Downe-Wamboldt
Journal:  Health Care Women Int       Date:  1992 Jul-Sep

2.  Characteristics associated with HIV infection among heterosexuals in urban areas with high AIDS prevalence --- 24 cities, United States, 2006-2007.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-08-12       Impact factor: 17.586

3.  Public health triangulation: approach and application to synthesizing data to understand national and local HIV epidemics.

Authors:  George W Rutherford; William McFarland; Hilary Spindler; Karen White; Sadhna V Patel; John Aberle-Grasse; Keith Sabin; Nathan Smith; Stephanie Taché; Jesus M Calleja-Garcia; Rand L Stoneburner
Journal:  BMC Public Health       Date:  2010-07-29       Impact factor: 3.295

4.  Treatment of sexually transmitted infections for HIV prevention: end of the road or new beginning?

Authors:  Richard Hayes; Deborah Watson-Jones; Connie Celum; Janneke van de Wijgert; Judith Wasserheit
Journal:  AIDS       Date:  2010-10       Impact factor: 4.177

  4 in total
  3 in total

1.  Enhancing HIV Prevention and Care Through CAPUS and Other Demonstration Projects Aimed at Achieving National HIV/AIDS Strategy Goals, 2010-2018.

Authors:  David W Purcell; Stephen A Flores; Linda J Koenig; Janet C Cleveland; Jonathan Mermin
Journal:  Public Health Rep       Date:  2018 Nov/Dec       Impact factor: 2.792

2.  Improving Linkage, Retention, and Reengagement in HIV Care in 12 Metropolitan Areas.

Authors:  Mary Spink Neumann; James W Carey; Stephen A Flores; Holly H Fisher; Tamika Hoyte; Nicole Pitts; Monique Carry; Arin Freeman
Journal:  Health Promot Pract       Date:  2017-12-01

3.  The First 40 Years of AIDS: Promising Programs, Limited Success.

Authors:  William W Darrow
Journal:  AIDS Behav       Date:  2021-10-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.